Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.134 | SGLT-2 inhibition for atrial functional mitral regurgitation: A randomized, double-blind, parallel-group, placebo-controlled trial (SAFARI study) |
Prof. LEE Alex Pui Wai 李沛威 |
| 2023.137 | INDICAID COVID-19/FLU A&B Rapid Antigen Test Retrospective Clinical Study |
Dr. CHAN Wan Yi 陳韻怡 |
| 2023.136 | VALidation of the performance of portable AI Ultrasound image in novicE (VALUE study) |
Prof. LEE Alex Pui Wai 李沛威 |
| 2023.153 | Mitochondrial disease related mortality - evaluation of a large international cohort | Dr. MA Kam Hung |
| 2023.174 | Using mesenchymal stem cells (MSCs) derived from infrapatellar fat pad (IFP) excised during total knee replacement of advanced aged OA patients for osteochondral tissue engineering |
Prof. YUNG Shu Hang 容樹恒 |
| 2023.133 | A prospective evaluation of early return-to-work (RTW) intervention group for patients with lower limbs injury in work rehabilitation program |
Ms. CHAN Sui Mei 陳瑞薇 |
| 2023.132 | Transcranial Direct Current Stimulation in Post-Stroke Fatigue: A Pilot Study |
Professor TANG Wai Kwong 鄧偉光 |
| 2023.131 | Depicting breast cancer on digital mammography by artificial intelligence-based computer-assisted diagnosis – the strengths and weaknesses | Dr. YU Suet Mui |
| 2023.130 | Commercial AI for Detection of SAH on Head CT Scans | Dr. WEI Jeremy Lok |
| 2023.129 | Augmented Reality-Guided Home-based Frailty Management Programme on Physical and Psychological Outcomes in Community-dwelling Older Adults with Frailty: A feasibility randomised controlled trial |
Mr. TAO An 陶安 |
| 2023.127 | Machine learning models to quantify and predict radiographic joint damage in rheumatoid arthritis |
Prof. TAM Lai Shan Lai Shan TAM |
| 2023.128 | Causal Machine learning models for prediction of major adverse cardiovascular events in inflammatory arthritis: a population-based study | Dr. SO Ho |
| 2023.125 | Effectiveness of Cognitive Activity Training Program (CATP) on mild NCD patients at a hospital out-patient setting: A quasi experimental study | Mr. LI King Lok |
| 2023.126 | Proteomic profile in women with endometriosis (PROTEO-ENDO) study | Dr. CHEUNG Eva Chun Wai |
| 2023.124 | Improved Free-Breathing Abdominal Magnetic Resonance Imaging Using Deep Learning | Prof. CHANG Hing Chiu |
| 2023.122 | A Belt and Road platform to track and tackle MRSA disease and carriage, elucidating their antimicrobial and biocide resistance, genetic diversity and transmission dynamics between humans, animals and the environment | Prof. IP Margaret |
| 2023.123 | HLA-typing of donor-origin cells enriched from urine-derived cell culture of kidney transplanted recipients | Dr. CHOW Kai Ming |
| 2023.116 | A Pilot Study on the Effectiveness of Mobile-Health assisted Music Therapy in Improving Upper Limb Function of Stroke Patients in Outpatient Clinics | Ms. CHOI Grace Wai Kwan |
| 2023.114 | RNA m6A去甲基化酶ALKBH5对结直肠癌化疗疗效的影响及作用机制 (Targeting RNA m6A eraser ALKBH5 boosts the efficacy of chemotherapy in colorectal cancer) |
Prof. YU Jun 于君 |
| 2023.107 | Videoconferencing-based Focused Acceptance and Commitment Therapy for parents of children with special health care needs: A non-randomised controlled feasibility trial | Prof. CHONG Yuen Yu |
| 2023.108 | The effectiveness of AI-assisted bowel preparation evaluation before colonoscopy. A prospective, single-blinded, randomized-controlled trial | Prof. TANG Raymond S.Y. |
| 2023.115 | Prospective evaluation of the aetiologies, management and clinical outcomes in patients with pleural effusion | Prof. CHAN Ken Ka Pang |
| 2023.109 | Effects of a structured, family-supported, and patient-centred advance care planning on end-of-life decision making among palliative care patients and their family members: A randomized controlled trial | Dr. LO Raymond See Kit |
| 2023.110 | A pilot study comparing the clinical efficacy and bleeding risk between low dose and standard dose intrapleural tissue plasminogen activator for pleural infection | Prof. CHAN Ken Ka Pang |
| 2023.117 | Identification of novel therapeutic targets in gastric cancer with lymph node or distant metastasis: An explorative study |
Dr. CHAN Shannon Melissa 陳詩瓏 |
| 2023.111 | Body composition and growth after adenotonsillectomy for childhood obstructive sleep apnoea – a prospective longitudinal study | Prof. LI Albert Martin |
| 2023.092 | Microwave Ablation and Superheated Steam Endobronchial Treatment of Lung Primary and Oligometastatic tumours (MASS trial) |
Prof. NG Calvin Sze Hang 吳士衡 |
| 2023.093 | Conservative treatment for triggering finger - A randomized trial comparing effectiveness of thermoplastic finger blocking splints at metacarpophalangeal joint (MCPJ) and proximal interphalangeal joint (PIPJ). | Ms SUN Hoi Ki |
| 2023.105 | The role of macrophage lipid transfer in driving immunotherapy resistance of hepatocellular carcinoma cells | Prof. CHENG Alfred Sze Lok |
| 2023.095 | Study of product of conception derived from ultrasound-guided manual vacuum aspiration |
Prof. CHUNG Jacqueline Pui Wah Pui Wah Jacqueline Chung |
| 2023.094 | Randomized Controlled Trial of Bioabsorbable Steroid Eluting Stent in Frontal Sinus Opening for Endotype II Bilateral Chronic Rhinosinusitis with Nasal Polyps in the Asian Population | Dr. YEUNG David |
| 2023.096 | Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients |
Dr CHUNG Jacqueline Pui Wah 鍾佩樺 |
| 2023.118 | Identifying genetic determinants of drug response in Chinese patients with type 2 diabetes for precision therapeutics |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2023.165 | JET Enhanced Thrombectomy intervention Hong Kong Post Market Study |
Prof. TAN GuangMing 譚廣明 |
| 2023.097 | Investigating blood nucleases activity as a governing factor of molecular properties of plasma DNA | Dr. LAM Jacky Wai Kei |
| 2023.098 | A randomized trial of Danshen/Gegen in slowing cognitive decline in clinical AD and cerebral small vessel disease |
Professor Kwok Timothy 郭志銳 |
| 2023.113 | Neural Encoding of Speech in Chinese-Learning Children | Prof. WONG Patrick Chun Man |
| 2023.104 | A Phase IIIb Single Arm, Open-label, Multicentre Study of Durvalumab and Tremelimumab as First Line Treatment in Participants with Advanced Hepatocellular Carcinoma (SIERRA) | Prof. CHAN Stephen Lam |
| 2023.103 | A Phase II, Open-Label, Multi-Drug, Multi-Centre, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary) Sub-study 1: Hepatocellular Carcinoma (HCC) | Prof. CHAN Stephen Lam |
| 2023.102 | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1 | Prof. YEO Winnie Ming Ming |
| 2023.099 | Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer: an open-label, multicenter, single arm phase 2 study |
Dr. LI Siu Ching 李兆澄 |
| 2023.100 | Preventive effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice: A Randomized Double-Blind Placebo-Controlled Parallel-Group Superiority Clinical Trial | Dr. LAU So Ling |
| 2023.101 | Effect of IL24-expressing mesenchymal stem cells on immune system in lung cancer patients and health donors |
Dr. LI Siu Ching 李兆澄 |
| 2023.089 | Identifying novel cell subpopulation and therapeutic target for adolescent idiopathic scoliosis through combined single-nucleus and spatial transcriptomics |
Prof. LEE Wayne Yuk Wai 李郁偉 |
| 2023.088 | Manufacturing process development and validation for human mesenchymal stem cells cell bank in compliance with current Good Manufacturing Practice (cGMP) standard. |
Prof. LEE Wayne Yuk Wai 李郁偉 |
| 2023.091 | Renal, metabolic, hepatic and bone outcomes in people living with HIV and other co-morbidities receiving different anti-retroviral regimens |
Dr. LUI Grace Chung Yan 雷頌恩 |
| 2023.120 | The Hong Kong Genome Project | Prof. LO Dennis Yuk Ming |
| 2023.087 | Using inflammatory markers and microRNA to identify obese individuals at risk of nonalcoholic steatohepatitis | Prof. KONG Alice Pik Shan |
| 2023.121 | Evaluation of the effectiveness of tele-care group therapy for patient with common mental disorder | Ms. LEE Kwun Yan |
| 2023.079 | A multi-centre trial on Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigation: The VIOLETTA trial |
Dr. CHIU Peter Ka Fung 趙家鋒 |
Page 14 of 248.